Atlas market file · Equity · United States
Real Brokerage IncREAX
- Last close
- 2.14
- Change
- +7.54%
- 96-bar range
- 1.55 – 2.83
- As of
- 7 Aug 2026
Real Brokerage Inc is a real estate agents & managers (for others) issuer listed as REAX on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
REAX
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-67.87% over the window).
Source rail: Yahoo Finance chart API (REAX). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for REAX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
REAX public profile
Real estate agents & managers (for others) issuer. Real Brokerage Inc is connected to current market context, cited company sources and its retained research file.
Real Brokerage Inc trades as REAX on NASDAQ. Real Brokerage Inc (REAX) has a latest verified close of 2.14, up 7.54%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files REAX under USA Stocks and Financial Stocks for browsing.
What changed for Real Brokerage Inc today
Real Brokerage Inc (REAX) closed fiscal 2025 with $1.97B in revenue but a staggering $8.1M net loss, raising eyebrows over its ability to turn scale into profit. The company’s latest 40-F filing reveals a diluted EPS of -$0.04 and just $33.2M in cash despite $65.9M in operating cash flow, suggesting operational leaks that could test investor patience.
REAX’s proposed merger with REMAX Holdings has dominated recent filings, with July 14th 6-K and 425 submissions highlighting regulatory and securityholder approval hurdles. The company’s R&D spend of $17.4M-nearly 10% of its cash reserves-underscores its bet on innovation, though the lack of corresponding profit raises questions about execution.
The brokerage’s mortgage and title services remain 'available only in certain markets,' per its July 9th filing, a limitation that could constrain growth. With liabilities of $75.3M against equity of $51.7M, REAX’s balance sheet leans precarious, and its ability to attract agents in competitive markets remains unproven.
Chart-wise, REAX’s liquidity profile is a concern: its weighted average diluted shares of 219.9M suggest dilution risks, while the lack of buyback disclosures in recent filings leaves little cushion for shareholders. The stock’s performance will hinge on merger completion and regional expansion, both of which face execution and regulatory headwinds.
Sources & evidence · 9 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
REAX technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on REAX
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep REAX research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
REAX FAQ
What is Real Brokerage Inc (REAX)?Real Brokerage Inc (REAX) has a latest verified close of 2.14, up 7.54%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...
Real Brokerage Inc (REAX) has a latest verified close of 2.14, up 7.54%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for REAX?Real Brokerage Inc (REAX) has a latest verified close of 2.14, up 7.54%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks...
Real Brokerage Inc (REAX) has a latest verified close of 2.14, up 7.54%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files REAX under USA Stocks and Financial Stocks for browsing.
How often is the REAX page updated?The REAX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The REAX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for REAX?The REAX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:REAX. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The REAX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:REAX. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on REAX?Yes. The workstation can open REAX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open REAX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this REAX page investment advice?No. The REAX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The REAX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →